Advanced search
Start date

Evaluation of bioadhesion from lipid nanoparticles containing curcumin coated with chitosan and functionalized with CEACAM-1 in clinical isolates of Helicobacter pylori

Grant number: 22/15987-4
Support Opportunities:Scholarships abroad - Research Internship - Doctorate
Effective date (Start): February 28, 2023
Effective date (End): February 14, 2024
Field of knowledge:Health Sciences - Pharmacy - Pharmaceutical Technology
Principal Investigator:Marlus Chorilli
Grantee:Bruna Almeida Furquim de Camargo
Supervisor: Maria Cristina Teixeira Lopes da Costa Pinto Lopes Martins
Host Institution: Faculdade de Ciências Farmacêuticas (FCFAR). Universidade Estadual Paulista (UNESP). Campus de Araraquara. Araraquara , SP, Brazil
Research place: Universidade do Porto (UP), Portugal  
Associated to the scholarship:19/25056-5 - Evaluation of the potential of curcumin loaded- CEACAM-1 functionalized nanostructured lipid carriers in the treatment of Helicobacter pylori infections, BP.DR


Helicobacter pylori is a bacterium that colonizes the gastric epithelium and is often associated with gastric disorders such as gastritis, ulcers, and may even progress to gastric cancer. Its ability to penetrate the gastric mucus and form biofilms makes its treatment difficult. Therefore, new alternatives are sought, such as the use of natural products with antimicrobial activity, such as curcumin. However, its lipophilic nature hinders its solubility in water, reducing its bioavailability. Nanostructured lipid carriers (NLC) are considered innovative nanoparticles for the incorporation of lipophilic drugs. Furthermore, the surfaces of these NLCs can be coated with chitosan, allowing, in addition to mucoadhesion of the system, functionalization with signaling molecules, such as cell adhesion molecules related to human carcinoembryonic antigen (CEACAMs). Thus, this project aims to evaluate the performance of the drug delivery system already developed in the beneficiary's project in the country against the multiresistant clinical strain of H. pylori, in addition to evaluating the stability in the gastric environment and the capacity of bioadhesion to the bacteria. It will also evaluate the influence of the system on the ability of bacteria to adhere to a gastric cancer cell line and its cytotoxicity. Thus, it is expected that the system already developed will present antibacterial activity against the clinical strain of H. pylori. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Please report errors in scientific publications list using this form.